rs147953784

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001173990.3(TMEM216):​c.35-17C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00571 in 1,530,872 control chromosomes in the GnomAD database, including 71 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0051 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0058 ( 65 hom. )

Consequence

TMEM216
NM_001173990.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.113

Publications

1 publications found
Variant links:
Genes affected
TMEM216 (HGNC:25018): (transmembrane protein 216) This locus encodes a transmembrane domain-containing protein. Mutations at this locus have been associated with Meckel-Gruber Syndrome Type 2, and Joubert Syndrome 2, also known as Cerebello-oculorenal Syndrome 2. [provided by RefSeq, Aug 2010]
TMEM216 Gene-Disease associations (from GenCC):
  • Joubert syndrome 2
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Joubert syndrome with oculorenal defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • orofaciodigital syndrome type 6
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 11-61393214-C-T is Benign according to our data. Variant chr11-61393214-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257597.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00513 (782/152312) while in subpopulation SAS AF = 0.024 (116/4830). AF 95% confidence interval is 0.0205. There are 6 homozygotes in GnomAd4. There are 419 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMEM216NM_001173990.3 linkc.35-17C>T intron_variant Intron 1 of 4 ENST00000515837.7 NP_001167461.1 Q9P0N5-1
TMEM216NM_001173991.3 linkc.35-17C>T intron_variant Intron 1 of 4 NP_001167462.1 Q9P0N5-3
TMEM216NM_016499.6 linkc.-149-17C>T intron_variant Intron 1 of 4 NP_057583.2 Q9P0N5-2
TMEM216NM_001330285.2 linkc.-149-17C>T intron_variant Intron 1 of 4 NP_001317214.1 Q9P0N5J3QT25

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMEM216ENST00000515837.7 linkc.35-17C>T intron_variant Intron 1 of 4 2 NM_001173990.3 ENSP00000440638.1 Q9P0N5-1
TMEM216ENST00000334888.10 linkc.35-17C>T intron_variant Intron 1 of 4 2 ENSP00000334844.5 Q9P0N5-3

Frequencies

GnomAD3 genomes
AF:
0.00514
AC:
783
AN:
152194
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.00766
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0242
Gnomad FIN
AF:
0.00283
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00663
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00785
AC:
1067
AN:
135982
AF XY:
0.00933
show subpopulations
Gnomad AFR exome
AF:
0.000156
Gnomad AMR exome
AF:
0.00477
Gnomad ASJ exome
AF:
0.00146
Gnomad EAS exome
AF:
0.000287
Gnomad FIN exome
AF:
0.00507
Gnomad NFE exome
AF:
0.00686
Gnomad OTH exome
AF:
0.00703
GnomAD4 exome
AF:
0.00577
AC:
7956
AN:
1378560
Hom.:
65
Cov.:
28
AF XY:
0.00647
AC XY:
4400
AN XY:
680562
show subpopulations
African (AFR)
AF:
0.000762
AC:
24
AN:
31478
American (AMR)
AF:
0.00455
AC:
162
AN:
35600
Ashkenazi Jewish (ASJ)
AF:
0.00243
AC:
61
AN:
25074
East Asian (EAS)
AF:
0.000224
AC:
8
AN:
35682
South Asian (SAS)
AF:
0.0221
AC:
1750
AN:
79036
European-Finnish (FIN)
AF:
0.00322
AC:
109
AN:
33858
Middle Eastern (MID)
AF:
0.0338
AC:
192
AN:
5676
European-Non Finnish (NFE)
AF:
0.00492
AC:
5289
AN:
1074446
Other (OTH)
AF:
0.00626
AC:
361
AN:
57710
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
393
785
1178
1570
1963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00513
AC:
782
AN:
152312
Hom.:
6
Cov.:
32
AF XY:
0.00563
AC XY:
419
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41564
American (AMR)
AF:
0.00765
AC:
117
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5180
South Asian (SAS)
AF:
0.0240
AC:
116
AN:
4830
European-Finnish (FIN)
AF:
0.00283
AC:
30
AN:
10618
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00663
AC:
451
AN:
68026
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
37
74
112
149
186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00692
Hom.:
1
Bravo
AF:
0.00474
Asia WGS
AF:
0.00693
AC:
24
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 28, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
May 08, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Joubert syndrome 2 Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 19, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Meckel syndrome, type 2 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Joubert syndrome Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.5
DANN
Benign
0.55
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147953784; hg19: chr11-61160686; API